Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
 |
New Vision (Kampala) - November 8, 2006
Cyprian Musoke
The Fund's Communications Manager, Nicolas Demey, yesterday said although Uganda submitted proposals for HIV/AIDS, malaria and tuberculosis (TB), only the latter was granted.
He, however, left open a window of hope, saying once the issues have been addressed, Uganda is not precluded from receiving new grant support.
"Uganda submitted three proposals for all three diseases HIV/AIDS, TB and malaria. Only the TB proposal has been approved by the Board of the Global Fund. As you will probably know, all grant proposals that have been received by the Global Fund have first been reviewed for technical merit by the Technical Review Panel (TRP), which is an independent panel of health and development experts.
"Based on the TRP's evaluation, proposals have been recommended to the Board for funding. As is with all countries, weaknesses in implementation of prior grants are considered by the TRP, however, providing that these issues have been addressed, countries like Uganda are not precluded from receiving new grant support.
"The TRP must have had some concerns with Uganda's HIV/AIDS and malaria bids, regarding the technical merit and past implementation, and decided not to recommend them to the Board for funding," he said.
Health minister Stephen Mallinga could not be reached for a comment as he is in Geneva attempting to salvage Uganda's funding.
061108
NV061116
Copyright © 2006 - The New Vision. All articles are republished on AEGIS by permission. Material may not be redistributed, posted to any other location, published or used for broadcast without written authorization from Managing Director/Editor-in-chief, The New Vision, P.O. Box 9815, Kampala - Uganda, Tel/fax: 256-41-235221, E-mail: wpike@newvision.co.ug.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .